DE69924304D1 - N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin - Google Patents

N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin

Info

Publication number
DE69924304D1
DE69924304D1 DE69924304T DE69924304T DE69924304D1 DE 69924304 D1 DE69924304 D1 DE 69924304D1 DE 69924304 T DE69924304 T DE 69924304T DE 69924304 T DE69924304 T DE 69924304T DE 69924304 D1 DE69924304 D1 DE 69924304D1
Authority
DE
Germany
Prior art keywords
palmitoylethanolamide
pharmaceutical compositions
veterinary medicine
containing pharmaceutical
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69924304T
Other languages
English (en)
Other versions
DE69924304T2 (de
Inventor
Cristina Comelli
Valle Federica Della
Valle Francesco Della
Gabriele Marcolongo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovet Italia SRL
Original Assignee
Innovet Italia SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11333115&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69924304(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innovet Italia SRL filed Critical Innovet Italia SRL
Application granted granted Critical
Publication of DE69924304D1 publication Critical patent/DE69924304D1/de
Publication of DE69924304T2 publication Critical patent/DE69924304T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69924304T 1999-08-06 1999-08-06 N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin Expired - Lifetime DE69924304T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT1999/000259 WO2001010434A1 (en) 1999-08-06 1999-08-06 Pharmaceutical compositions containing n-palmitoylethanolamide and use thereof in the veterinary field

Publications (2)

Publication Number Publication Date
DE69924304D1 true DE69924304D1 (de) 2005-04-21
DE69924304T2 DE69924304T2 (de) 2006-04-13

Family

ID=11333115

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69924304T Expired - Lifetime DE69924304T2 (de) 1999-08-06 1999-08-06 N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin

Country Status (7)

Country Link
US (1) US6548550B1 (de)
EP (1) EP1207870B1 (de)
AT (1) ATE290858T1 (de)
DE (1) DE69924304T2 (de)
DK (1) DK1207870T3 (de)
ES (1) ES2239453T3 (de)
WO (1) WO2001010434A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0211251B1 (pt) † 2001-07-18 2013-09-17 composição para o tratamento de cabelo e/ou couro cabeludo.
TWI250023B (en) * 2001-10-22 2006-03-01 Santen Pharmaceutical Co Ltd Pharmaceutical composition for itch treating agent
US8298553B2 (en) * 2007-12-06 2012-10-30 Conopco, Inc. Personal care composition
CN102186459A (zh) * 2009-09-07 2011-09-14 晶源集团股份责任有限公司 含有超微粒化十六酰胺乙醇的组合物
EP2444078B1 (de) 2010-10-04 2017-09-13 EPITECH GROUP S.p.A. Verwendung von amiden von mono- und dicarboxylsäuren bei der behandlung von nierenkrankheiten
ITMI20131132A1 (it) 2013-07-05 2015-01-06 Epitech Group Srl Uso in combinazione di amidi di acidi mono- e dicarbossilici e silimarina nel trattamento di patologie renali
ES2603809T3 (es) 2014-03-19 2017-03-01 Epitech Group S.R.L. Composición farmacéutica que comprende palmitoiletanolamida y L-acetilcarnitina
EP2944309B1 (de) 2014-05-14 2019-03-20 EPITECH GROUP S.p.A. Verwendung von palmitoylethanolamid in kombination mit opioiden
PL2965765T3 (pl) 2014-07-08 2019-11-29 Epitech Group S P A Zastosowanie adelmidrolu w leczeniu dysfunkcji nabłonka
ES2641143T3 (es) 2014-08-13 2017-11-07 Epitech Group S.P.A. Una composición farmacéutica que comprende palmitoiletanolamida y citidina-difosfocolina
NL2014464B1 (en) 2015-03-16 2017-01-13 Vanderbilt Science Holding Ltd Composition for use in the treatment of neuropathic pain.
WO2016183134A1 (en) * 2015-05-12 2016-11-17 Cutting Edge Medical Solutions, Llc Palmitoylethanolamide compositions
NL2017559B1 (en) * 2016-09-30 2018-04-10 Vanderbilt Science Holding Ltd Method for preparing pulverized palmitoylethanolamide particles, particles obtainable by the method, and apharmaceutical or neutraceutical composition comprising saidparticles
IT202000007831A1 (it) 2020-04-14 2021-10-14 Epitech Group S P A Adelmidrol per l’uso nel trattamento della fibrosi polmonare
IT202100024464A1 (it) * 2021-09-23 2023-03-23 Epitech Group S P A N-palmitoil-etanolamide e acido docosaesaenoico per l’uso nel trattamento del disturbo dello spettro autistico e di altre sindromi depressive
EP4331577A1 (de) 2022-08-30 2024-03-06 Unifarco S.p.A. Eine palmitoylethanolamid enthältende nutrazeutische tablette

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1252866B (it) * 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli con acidi policarbossilici atti alla modulazione dei mastociti nei processi infiammatori su base neuroimmunogenica
IT1252865B (it) * 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli attivi come autocoidi locali ed utilizzabili nella terapia dei processi autoimmuni
IT1271266B (it) * 1994-12-14 1997-05-27 Valle Francesco Della Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
CA2232191C (en) * 1995-09-19 2011-03-15 Solomon B. Margolin Inhibition of tumor necrosis factor alpha

Also Published As

Publication number Publication date
ATE290858T1 (de) 2005-04-15
DE69924304T2 (de) 2006-04-13
WO2001010434A1 (en) 2001-02-15
US6548550B1 (en) 2003-04-15
EP1207870B1 (de) 2005-03-16
DK1207870T3 (da) 2005-08-01
EP1207870A1 (de) 2002-05-29
ES2239453T3 (es) 2005-09-16

Similar Documents

Publication Publication Date Title
DE69924304D1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
DK0740650T3 (da) Codrugs som metode til styret transport af lægemiddel
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
DE60001546D1 (de) Liponsaürederivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
PT1119543E (pt) N-aralquilaminotetralinas como ligandos para o receptor y5 do neuropeptido y
ATE252562T1 (de) Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
BR0015506A (pt) Conjugados de interferon gama, métodos para sua preparação, composições farmacêuticas que compreendem ás moléculas e seu uso no tratamento de doenças
CO4290417A1 (es) Nuevas benzoilguanidinas como medicamentos y su preparacion .
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
BRPI0409523A (pt) método para o tratamento da dor neuropática, método de identificação de um composto e composição farmacêutica
DE59906017D1 (de) Benzocycloheptene, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten sowie deren verwendung zur herstellung von arzneimitteln
ATE243196T1 (de) Piperidine und pyrrolidine
DE60301570D1 (de) 1,2,3-substituierte indolizinderivate, fgf inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
BRPI0411503A (pt) composto, composição farmacêutica, uso de um composto, método de tratar um ser humano que sofre de uma doença hiperproliferativa tal como cáncer, e, processo para a preparação de um composto
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
DE69934781D1 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
EE04346B1 (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
BR9913718A (pt) Processo e composição farmacêutica ou veterinária para inibição profilática ou terapêutica de um material ou substância tóxica em um paciente animal humano ou não-humano, e, uso de um dendrìmero aniÈnico ou catiÈnico
DE60033519D1 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings